Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry
Link
https://link.springer.com/content/pdf/10.1007/s10989-022-10477-z.pdf
Reference74 articles.
1. Agarwal G, Gabrani R (2020) Antiviral peptides: identification and validation.International Journal of Peptide Research and Therapeutics, 1
2. Ahmadi K, Farasat A, Rostamian M, Johari B, Madanchi H (2022) Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study. J Biomol Struct Dynamics 40(12):5566–5576
3. Anderson G, Reiter RJ (2020) Melatonin: roles in influenza, Covid-19, and other viral infections.Reviews in Medical Virology, 30(3), e2109
4. Badani H, Garry RF, Wimley WC (2014) Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity. Biochim et Biophys Acta (BBA)-Biomembranes 1838(9):2180–2197
5. Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P (2006) Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res 69(1):39–45
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evolution of drug resistance against antiviral agents that target cellular factors;Virology;2024-12
2. Peptide-Based Drugs: Development and Therapeutic Applications;Journal for Research in Applied Sciences and Biotechnology;2024-08-25
3. Chemically Peptide Synthesis and Role of Arginine and Lysine in the Antimicrobial and Antiviral Activity of Synthetic Peptides: A Comprehensive Review;Peptide Science;2024-06-25
4. Recent Advances on Targeting Proteases for Antiviral Development;Viruses;2024-02-27
5. A novel nanocomposite drug delivery system for SARS-CoV-2 infections;Nanoscale Advances;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3